Company intelligence / Profile preview

Navin Molecular

Dewas, Madhya Pradesh, Indianavinmolecular.com ↗

Ownership: Private
Employees: ~350
Development stage: Commercial

Overview

Navin Molecular is an active CDMO specializing in custom synthesis, process & analytical development, and GMP/commercial manufacturing of small molecule intermediates. It has extensive expertise in fluorination and hazardous chemistries. The company does not have its own clinical pipeline but enables pharma/biotech clients to advance their molecules through all phases by providing regulatory starting materials and advanced intermediates with global quality standards. Recent investments are expanding R&D capacity and GMP manufacturing infrastructure at its Dewas site.

Therapeutic areas: Other
Modalities: Small molecule
Industry: Contract Manufacturing Organization

Partnerships

No specific partnerships disclosed publicly; works with global pharmaceutical innovators as customers

Beyond the preview

Go deeper on Navin Molecular.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Navin Molecular.

Explore the full profile